ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

NMOSD and MOGAD Clinical Trials

Siegel Rare Neuroimmune Association

M. Levy

ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara

CMSC 2021 Highlight: Complex Visual Symptoms in MS & Revisiting the …

Robert Shin

Management of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2022

University of Miami

L. Tornes

MOG Antibody-Associated Bilateral Optic Neuritis Associated with Joh…

2023 Conference Coverage

F. Mutete

Optic Neuritis: Case-Based Discussions

ZINCARE

N. Naamuah Tagoe

The Role of Optical Coherence Tomography in Neurology

University of Miami

H. Jiang

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

University of Miami

H. Jiang

Myelitis vs. Myelopathies: A Primer for Residents

ZINCARE

C. A. Pardo

Advances in Diagnostics and Therapeutic Management of Optic Neuritis…

Houston Methodist

A. Lee

Imaging Features of MOGAD and Key Flags

Giulia Fadda

Diagnostic Criteria for Myelin Oligodendrocyte Glycoprotein Antibody…

Cleveland Clinic Neurological Institute

J. R. Abbatemarco

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

University of Miami

F. Nelson

The Current Spectrum of NMOSD

Olga Rosenvald Thon

Immune Checkpoint Inhibitors and Neurological Adverse Events

Cleveland Clinic Neurological Institute

A. Kunchok

Neuroimaging Case Studies in Inflammation and Demyelination

2023 Conference Coverage

U. Kaunzner

Neuromyelitis Optica Spectrum Disorder: Creation and Evolution

Barrow Neurological Institute

D. Wingerchuk

Everything a Neurologist Needs to Know About NMO & MOG

University of Miami

M. Levy